NATCO Pharma Invests Additional USD 14 Million in eGenesis, Total Investment Hits USD 22 Million Written By sheeba farhat25 Aug 2026 6:45 PM ISTHyderabad: NATCO Pharma Limited has announced an additional investment of USD 14 million in US-based biotechnology company eGenesis, Inc., taking its...
NATCO Pharma's Visakhapatnam Plant Gets 4 USFDA Observations Written By Parthika Patel23 Aug 2026 8:49 PM ISTHyderabad: NATCO Pharma Limited has announced the conclusion of a US Food and Drug Administration (USFDA) inspection at its Finished Dosage...
Natco Moves Delhi HC Against Ribociclib Patent Written By Susmita Roy6 Aug 2026 8:30 PM ISTNew Delhi: The Delhi High Court has sought responses from the Controller of Patents, Swiss pharmaceutical company Novartis AG, UK-based Astex...
Alembic, NATCO Receive USFDA Tentative Approval for Generic Cancer Drug Olaparib Written By sheeba farhat20 July 2026 8:33 PM ISTMumbai: Alembic Pharmaceuticals Limited (Alembic) has announced that its Partner NATCO Pharma Limited (NATCO) has received tentative approval from the...
NATCO Pharma Completes Rs 1,060 Crore Adcock Ingram Stake Acquisition Written By sheeba farhat14 July 2026 10:15 AM ISTNew Delhi: NATCO Pharma Limited has completed the acquisition of an additional 13.25% equity stake in South Africa-based pharmaceutical and healthcare...
Natco Pharma to Raise Stake in South Africa's Adcock Ingram to 49% in Rs 1,069 Crore Deal Written By sheeba farhat10 July 2026 12:15 PM ISTNew Delhi: NATCO Pharma Limited has received approval from its Board of Directors to acquire an additional stake in South Africa-based Adcock Ingram...
Natco, Lupin Secure USFDA Nod for Generic Cancer Drug Eribulin Mesylate Injection Written By sheeba farhat3 Jun 2026 7:14 PM ISTNew Delhi: NATCO Pharma Limited and its alliance partner Lupin Limited has announced the approval from the United States Food and Drug Administration...
NPPA Slaps Natco Pharma with Rs 4.92 Crore Demand Notice Over Alleged Drug Overcharging Written By MD Bureau16 May 2026 10:18 PM ISTNew Delhi: Natco Pharma Limited has received a demand notice of over Rs 4.92 crore from the National Pharmaceutical Pricing Authority (NPPA) over...
Generic Semaglutide Therapy Cost in India May Drop to Rs 500 a Month: Report Written By Parthika Patel15 May 2026 10:46 PM ISTNew Delhi: Prices of generic semaglutide, the popular weight-loss and anti-diabetes drug, are expected to decline sharply in India over the next six...
Natco Pharma to Demerge Agrochemicals Arm, Approves Nigeria Entry and Australia Exit Written By Parthika Patel27 March 2026 11:18 PM ISTNew Delhi: The Board of Directors of Natco Pharma Limited has approved a Scheme of Arrangement for demerger of its agrochemicals business into a...
Natco Pharma Enters USD 3.2 Billion US Pomalidomide Market, Claims 180-Day Exclusivity Written By sheeba farhat5 March 2026 9:43 PM ISTHyderabad: NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide Capsules in the...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Written By Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
